Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.
Pediatric blood & cancer
, 2009 Feb: 169-76
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
, 2005 Jan 20: 525-31